![Colleen Delaney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colleen Delaney
Directeur/Membre du Conseil chez
VICAPSYS LIFE SCIENCES, INC.
Fortune : - $ au 31/07/2026
Profil
Colleen Delaney is the founder of Nohla Therapeutics, Inc., Deverra Therapeutics, Inc. Current positions include Director at American Society for Blood & Marrow Transplantation, Director at Vicapsys Life Sciences, Inc. since 2022, and Clinical Professor at the University of Washington.
Former positions include Professor at Fred Hutchinson Cancer Research Center, Professor at Fred Hutchinson Cancer Center, and Chief Scientific & Medical Officer at Coeptis Therapeutics Holdings, Inc. from 2023 to 2025.
Education includes graduate studies at the University of Oxford and a doctorate from Harvard Medical School conferred in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 26/03/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Colleen Delaney
| Sociétés | Poste | Début |
|---|---|---|
| VICAPSYS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 22/09/2022 |
American Society for Blood & Marrow Transplantation
 American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | Directeur/Membre du Conseil | - |
Deverra Therapeutics, Inc.
 Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies | Fondateur | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Colleen Delaney
| Sociétés | Poste | Fin |
|---|---|---|
| COEPTIS THERAPEUTICS | Directeur Technique/Scientifique/R&D | 24/03/2025 |
Fred Hutchinson Cancer Center
 Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer treatment center | Corporate Officer/Principal | - |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Corporate Officer/Principal | - |
Nohla Therapeutics, Inc.
 Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders | Fondateur | - |
Formation de Colleen Delaney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
American Society for Blood & Marrow Transplantation
American Society for Blood & Marrow Transplantation The American Society for Blood & Marrow Transplantation is a professional membership organization with over 3,900 members, including physicians, investigators, and healthcare professionals from more than 50 countries. The private company is based in Arlington Heights, IL. The organization is dedicated to advancing hematopoietic cell transplantation and related cellular therapies through research, education, advocacy, and clinical resources. It provides evidence-based practice guidelines, clinical calculators, coding and billing guides, educational courses, webinars, and publishes the peer-reviewed journal "Transplantation and Cellular Therapy." The society hosts scientific meetings, supports professional development, and collaborates with international organizations. Advocacy efforts focus on improving patient access to therapies, increasing NIH funding, and supporting critical programs. | |
Vicapsys Life Sciences, Inc.
 Vicapsys Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops transplantation therapies and encapsulated product candidates | Health Technology |
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer treatment center | Health Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular therapies for hematological disorders | Health Technology |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Develops off-the-shelf allogeneic cellular immunotherapies | Health Technology |
Coeptis Therapeutics Holdings, Inc.
 Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer | Health Technology |
